April 6, 2026 · Form 4 insider transaction
De Backer Marianne sold 72,559 shares of Vir Biotechnology, Inc. at $9.16 per share, a transaction worth $664.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.